Enteroviral meningitis: Natural history and outcome of pleconaril therapy

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 7, 2006, Pages 2409-2414

  Desmond, R A ^a   Accortt, N A ^a,e   Talley, L ^b   Villano, S A ^c   Soong, S J ^a   Whitley, R J ^a,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b EMMES CORPORATION   (United States)

^c ViroPharma Incorporated   (United States)

^d University of Alabama ^*  (United States)

^e WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLECONARIL;

ADULT; ARTICLE; BACKACHE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DYSPEPSIA; ENTEROVIRUS; FEMALE; FEVER; HEADACHE; HOSPITALIZATION; HUMAN; INSOMNIA; KAPLAN MEIER METHOD; MALE; MYALGIA; NAUSEA; PHOTOSENSITIVITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; VIRUS MENINGITIS; VIRUS REPLICATION; VOMITING;

ADULT; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; ENTEROVIRUS INFECTIONS; FEMALE; HEADACHE; HUMANS; MALE; MENINGITIS, VIRAL; MULTIVARIATE ANALYSIS; OXADIAZOLES; TREATMENT OUTCOME;

EID: 33745627804     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00227-06     Document Type: Article

References (11)

1. Abzug, M. J., G. Cloud, J. Bradley, P. J. Sanchez, J. Romero, D. Powell, M. Lepow, C. Mani, E. V. Capparelli, S. Blount, F. Lakeman, R. J. Whitley, D. W. Kimberlin, and National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 2003. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr. Infect. Dis. J. 22:335-341.
2. Celentano, D. D., M. S. Linet, and W. F. Stewart. 1990. Gender differences in the experience of headache. Soc. Sci. Med. 30:1289-1295.
3. Chambon, M., C. Archimbaud, J. L. Bailly, C. Henquell, C. Regagnon, F. Charbonne, and H. Peigue-Lafeuille. 2001. Circulation of enteroviruses and persistence of meningitis cases in the winter of 1999-2000. J. Med. Virol. 65:340-347.
4. Pevear, D. C., T. M. Tull, M. E. Seipel, and J. M. Groarke. 1999. Activity of pleconaril against enteroviruses. Antimicrob. Agents Chemother. 43:2109-2115.
5. Raftery, K. A., R. Smith-Coggins, and A. H. Chen. 1995. Gender-associated differences in emergency department pain management. Ann. Emerg. Med. 26:414-421.
6. Romero, J. R. 2001. Pleconaril: a novel antipicornaviral drug. Expert Opin. Investig. Drugs 10:369-379.
7. Rotbart, H. A. 1995. Enteroviral infections of the central nervous system. Clin. Infect. Dis. 20:971-981.
8. Rotbart, H. A., P. J. Brennan, K. H. Fife, J. R. Romero, J. A. Griffin, M. A. McKinlay, and F. G. Hayden. 1998. Enterovirus meningitis in adults. Clin. Infect. Dis. 27:896-898.
9. Rotbart, H. A., A. D. Webster, and Pleconaril Treatment Registry Group. 2001. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin. Infect. Dis. 32:228-235.
10. Stalkup, J. R., and S. Chilukuri. 2002. Enterovirus infections: a review of clinical presentation, diagnosis, and treatment. Dermatol. Clin. 20:217-223.
11. Tormey, V. J., J. R. Buscombe, M. A. Johnson, A. P. Thomson, and A. D. Webster. 2003. SPECT scans for monitoring response to pleconaril therapy in chronic enteroviral meningoencephalitis. J. Infect. 46:138-140.